{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:36:06Z","timestamp":1788582966263,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:00:00Z","timestamp":1559174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12325-019-00982-x","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T08:02:32Z","timestamp":1559203352000},"page":"2096-2105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impacts of Cytochrome P450 2D6*10 Allele and a High-Fat Meal on the Pharmacokinetics of Dapoxetine in Healthy Chinese Men: A Single-Dose, Two-Treatment Study"],"prefix":"10.1007","volume":"36","author":[{"given":"Shiwei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8070-3117","authenticated-orcid":false,"given":"Xuehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,30]]},"reference":[{"issue":"5","key":"982_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1756287212453866","volume":"4","author":"CG McMahon","year":"2012","unstructured":"McMahon CG. Dapoxetine: a new option in the medical management of premature ejaculation. Ther Adv Urol. 2012;4(5):233\u201351.","journal-title":"Ther Adv Urol"},{"issue":"9","key":"982_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/ijcp.12843","volume":"70","author":"A Russo","year":"2016","unstructured":"Russo A, Capogrosso P, Ventimiglia E, La Croce G, Boeri L, Montorsi F, et al. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review. Int J Clin Pract. 2016;70(9):723\u201333.","journal-title":"Int J Clin Pract"},{"issue":"2","key":"982_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1464-410X.2006.05911.x","volume":"97","author":"KE Andersson","year":"2006","unstructured":"Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for \u2018on-demand\u2019 treatment of premature ejaculation. BJU Int. 2006;97(2):311\u20135.","journal-title":"BJU Int"},{"issue":"3","key":"982_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0091270005284850","volume":"46","author":"NB Modi","year":"2006","unstructured":"Modi NB, Dresser MJ, Simon M, Lin D, Desai D, Gupta S. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol. 2006;46(3):301\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"982_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/0091270009333486","volume":"49","author":"NB Modi","year":"2009","unstructured":"Modi NB, Nath R, Staehr P, Gupta SK, Aquilina JW, Rivas D. Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. J Clin Pharmacol. 2009;49(6):634\u201342.","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"982_CR6","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1177\/0091270009359183","volume":"50","author":"A Thyssen","year":"2010","unstructured":"Thyssen A, Sharma O, Tianmei S, Aquilina JW, Vandebosch A, Wang SS, et al. Pharmacokinetics of dapoxetine hydrochloride in healthy Chinese, Japanese, and Caucasian men. J Clin Pharmacol. 2010;50(12):1450\u201360.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"982_CR7","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2165\/11204750-000000000-00000","volume":"70","author":"SM Hoy","year":"2010","unstructured":"Hoy SM, Scott LJ. Dapoxetine: in premature ejaculation. Drugs. 2010;70(11):1433\u201343.","journal-title":"Drugs"},{"issue":"9","key":"982_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0091270006291033","volume":"46","author":"MJ Dresser","year":"2006","unstructured":"Dresser MJ, Kang D, Staehr P, Gidwani S, Guo C, Mulhall JP, et al. Pharmacokinetics of dapoxetine, a new treatment for premature ejaculation: impact of age and effects of a high-fat meal. J Clin Pharmacol. 2006;46(9):1023\u20139.","journal-title":"J Clin Pharmacol"},{"key":"982_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpba.2015.11.018","volume":"119","author":"WM Zhang","year":"2016","unstructured":"Zhang WM, Qiang W, Ying-Fei W, Ming S, Wang R. Development and validation of a sensitive UPLC-MS\/MS method for the simultaneous determination of dapoxetine and its two metabolites in human plasma. J Pharm Biomed Anal. 2016;119:45\u20139.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"982_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"982_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2217\/pgs-2017-0194","volume":"18","author":"MA Bahar","year":"2017","unstructured":"Bahar MA, Setiawan D, Hak E, Wilffert B. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. Pharmacogenomics. 2017;18(7):701\u201339.","journal-title":"Pharmacogenomics"},{"issue":"1","key":"982_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2133\/dmpk.DMPK-11-RV-121","volume":"27","author":"LK Teh","year":"2012","unstructured":"Teh LK, Bertilsson L. Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metab Pharmacokinet. 2012;27(1):55\u201367.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"982_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/gim.2016.80","volume":"19","author":"A Gaedigk","year":"2017","unstructured":"Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS. Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med. 2017;19(1):69\u201376.","journal-title":"Genet Med"},{"issue":"1","key":"982_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cpt.597","volume":"102","author":"JK Hicks","year":"2017","unstructured":"Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, Muller DJ, Shimoda K, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37\u201344.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"982_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.clpt.6100455","volume":"83","author":"J Kirchheiner","year":"2008","unstructured":"Kirchheiner J. CYP2D6 phenotype prediction from genotype: which system is the best? Clin Pharmacol Ther. 2008;83(2):225\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"982_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00228-013-1573-x","volume":"70","author":"X Wu","year":"2014","unstructured":"Wu X, Yuan L, Zuo J, Lv J, Guo T. The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects. Eur J Clin Pharmacol. 2014;70(1):57\u201363.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"982_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2710.2008.00945.x","volume":"33","author":"SK Jin","year":"2008","unstructured":"Jin SK, Chung HJ, Chung MW, Kim JI, Kang JH, Woo SW, et al. Influence of CYP2D6*10 on the pharmacokinetics of metoprolol in healthy Korean volunteers. J Clin Pharm Ther. 2008;33(5):567\u201373.","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"982_CR18","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s12272-015-0646-z","volume":"38","author":"JY Byeon","year":"2015","unstructured":"Byeon JY, Kim YH, Na HS, Jang JH, Kim SH, Lee YJ, et al. Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites. Arch Pharm Res. 2015;38(11):2083\u201391.","journal-title":"Arch Pharm Res"},{"issue":"5","key":"982_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/tpj.2014.12","volume":"14","author":"P Gasso","year":"2014","unstructured":"Gasso P, Rodriguez N, Mas S, Pagerols M, Blazquez A, Plana MT, et al. Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. Pharmacogenomics J. 2014;14(5):457\u201362.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"982_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2710.2011.01298.x","volume":"37","author":"SJ Yin","year":"2012","unstructured":"Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. J Clin Pharm Ther. 2012;37(3):364\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"982_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.phrs.2016.04.019","volume":"110","author":"N Varela","year":"2016","unstructured":"Varela N, Quinones LA, Stojanova J, Garay J, Caceres D, Cespedes S, et al. Characterization of the CYP2D6 drug metabolizing phenotypes of the Chilean mestizo population through polymorphism analyses. Pharmacol Res. 2016;110:276.","journal-title":"Pharmacol Res"},{"issue":"11","key":"982_CR22","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2165\/11596010-000000000-00000","volume":"34","author":"M Harrison-Woolrych","year":"2011","unstructured":"Harrison-Woolrych M. Patient reporting encouraged during monitoring of dapoxetine in New Zealand. Drug Saf. 2011;34(11):1115\u20136.","journal-title":"Drug Saf"},{"issue":"12","key":"982_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.clinthera.2014.09.011","volume":"36","author":"J Li","year":"2014","unstructured":"Li J, Yuan H, Bai Y, Pu C, Tang Y, Dong Q, et al. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials. Clin Ther. 2014;36(12):2003\u201314.","journal-title":"Clin Ther"},{"issue":"4","key":"982_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.urology.2015.01.009","volume":"85","author":"FG Yue","year":"2015","unstructured":"Yue FG, Dong L, Hu TT, Qu XY. Efficacy of Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events. Urology. 2015;85(4):856\u201361.","journal-title":"Urology"},{"issue":"9539","key":"982_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","volume":"368","author":"JL Pryor","year":"2006","unstructured":"Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929\u201337.","journal-title":"Lancet"},{"issue":"1","key":"982_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11587660-000000000-00000","volume":"11","author":"PR Kowey","year":"2011","unstructured":"Kowey PR, Mudumbi RV, Aquilina JW, DiBattiste PM. Cardiovascular safety profile of dapoxetine during the premarketing evaluation. Drugs R D. 2011;11(1):1\u201311.","journal-title":"Drugs R D"},{"issue":"1","key":"982_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.xphs.2018.05.024","volume":"108","author":"C Tistaert","year":"2019","unstructured":"Tistaert C, Heimbach T, Xia B, Parrott N, Samant TS, Kesisoglou F. Food effect projections via physiologically based pharmacokinetic modeling: predictive case studies. J Pharm Sci. 2019;108(1):592\u2013602.","journal-title":"J Pharm Sci"},{"issue":"5","key":"982_CR28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00280-015-2708-9","volume":"75","author":"J de Jong","year":"2015","unstructured":"de Jong J, Sukbuntherng J, Skee D, Murphy J, O\u2019Brien S, Byrd JC, et al. The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia. Cancer Chemother Pharmacol. 2015;75(5):907\u201316.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1\u20132","key":"982_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijpharm.2016.04.006","volume":"505","author":"SA Fouad","year":"2016","unstructured":"Fouad SA, Shamma RN, Basalious EB, El-Nabarawi MA, Tayel SA. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: in-vitro\/in vivo evaluation. Int J Pharmaceut. 2016;505(1\u20132):212\u201322.","journal-title":"Int J Pharmaceut."},{"key":"982_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.apha.2018.04.007","volume":"83","author":"A Tornio","year":"2018","unstructured":"Tornio A, Backman JT. Cytochrome P450 in pharmacogenetics: an update. Adv Pharmacol. 2018;83:3\u201332.","journal-title":"Adv Pharmacol"},{"issue":"10","key":"982_CR31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/1440-1681.12978","volume":"45","author":"AN Dong","year":"2018","unstructured":"Dong AN, Tan BH, Pan Y, Ong CE. Cytochrome P450 genotype-guided drug therapies: an update on current states. Clin Exp Pharmacol Physiol. 2018;45(10):991\u20131001.","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00982-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00982-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00982-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T19:21:46Z","timestamp":1590693706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00982-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,30]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00982-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,30]]},"assertion":[{"value":"17 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}